Detalles de la búsqueda
1.
Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
Medicina (Kaunas)
; 59(6)2023 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37374209
2.
4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial.
Trop Med Int Health
; 25(4): 483-495, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31944502
3.
Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
Clin Infect Dis
; 59(10): e142-9, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25028463
4.
Assessing the utility of Truenat in extrapulmonary tuberculosis diagnosis - A NRL's experience.
J Clin Tuberc Other Mycobact Dis
; 35: 100420, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38440213
5.
Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial.
Open Forum Infect Dis
; 11(3): ofae034, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444824
6.
Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India.
Indian J Community Med
; 48(1): 103-107, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37082398
7.
Genotype MTBDRsl version 2 and phenotypic drug resistance detection of Mycobacterium tuberculosis for fluoroquinolones and aminoglycosides.
Int J Mycobacteriol
; 12(3): 299-304, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37721236
8.
Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity.
Sci Rep
; 13(1): 785, 2023 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646786
9.
Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis.
Sci Rep
; 13(1): 7404, 2023 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149713
10.
An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India.
Sci Rep
; 12(1): 6147, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413979
11.
Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis.
Front Immunol
; 13: 892701, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35911760
12.
Measuring tuberculosis patient perceived quality of care in public and public-private mix settings in India: an instrument development and validation study.
BMJ Open Qual
; 11(3)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788052
13.
Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome.
Ann Thorac Med
; 16(4): 323-328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820019
14.
Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates-Chennai, India, 2013-2016.
Front Microbiol
; 12: 720436, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34880835
15.
The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
PLoS One
; 15(11): e0241203, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147240
16.
Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
PLoS One
; 15(10): e0240594, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33057399
17.
Correction: Tuberculosis patients in an Indian mega-city: Where do they live and where are they diagnosed?
PLoS One
; 14(10): e0224808, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31665181
18.
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
JAMA Intern Med
; 178(4): 485-493, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29507938
19.
Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
PLoS One
; 13(7): e0200150, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29979738
20.
Indicators to Ensure Treatment Initiation of All Diagnosed Sputum Positive Pulmonary Tuberculosis Patients under Tuberculosis Control Programme in India.
Indian J Community Med
; 42(4): 238-241, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29184327